Dila Sayman

Dr. Dila Sayman

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in INTERNATIONAL REFEREED ACADEMIC JOURNAL OF SPORTS
Verified
Journal Article
Open access
PDF file
EÖEce Özdemi̇r Öktem
Ece Özdemi̇r Öktem
DSDila Sayman
Dila Sayman
AÖAhmet Özşimşek
Ahmet Özşimşek
ŞÇŞeyda Çankaya
Şeyda Çankaya
BYBurak Yulug
Burak Yulug
Aim: The aim of this study was to investigate the frequency, clinical and radiologic characteristics of cerebrovascular diseases associated with Covid-19 infection. Method: In this retrospective, descriptive study, 514 patients who were treated for cerebrovascular disease in our hospital between September 2020 and May 2022 were reviewed. Among 514 stroke patients, 44 patients who had acute cerebrovascular diseases during Covid-19 infection were included in the study. Demographic characteristics, comorbid conditions, stroke risk factors, magnetic resonance imaging findings, and laboratory test results were recorded. Results: Of the 500 patients retrospectively analyzed, 44 (8.8%) had a cerebrovascular event during Covid-19 infection. The mean age of the 44 patients included in the study was 72.02±10.36 years. Ischemic stroke was observed in 37 (84.1%) patients, intracranial hemorrhage in 5 (11.4%) patients and transient ischemic attack (TIA) in 2 (4.5%) patients. Anterior system infarcts were observed in 28 (77.8%) and posterior system infarcts in 8 (22.2%) patients with ischemic stroke. The most common infarct was determined as cardioembolic in nature (36.1%). The most common risk factor observed in patients was atherosclerosis and the most preferred treatment modality was acetylsalicylic acid. Conclusion: Cerebrovascular diseases during Covid-19 infection are frequently ischemic strokes involving the anterior system. Close neurological follow-up is recommended during Covid-19 infection, especially in elderly patients with atherosclerotic risk factors.

30 April 2024 in Academic Journal of Neurology and Neurosurgery
Verified
Journal Article
Open access
PDF file
DSDila Sayman
Dila Sayman
UDUmutcan Duran
Umutcan Duran
RKRamazan Karaca
Ramazan Karaca
ŞÇŞeyda Çankaya
Şeyda Çankaya
EÖEce Özdemir Öktem
Ece Özdemir Öktem
BYBurak Yulug
Burak Yulug
Gordon Holmes syndrome is an extremely rare, autosomal recessive condition with characteristic features of cerebellar progressive ataxia, cerebellar atrophy, and hypogonadotropic hypogonadism, which was first described in 1908 by the British neurologist of the same name. Two genes have to date been frequently associated with this syndrome, RNF216 and PNPLA61. A 23-year-old man presented with secondary sexual character deficiency and progressive difficulty in gait persisting for several years. He was eventually immobilized after seven years of ongoing symptoms and was definitively diagnosed with Gordon Holmes syndrome after genetic testing revealed RNF216 gene mutation.

29 October 2024 in Academic Journal of Neurology and Neurosurgery
Verified
Journal Article
Open access
PDF file
UDUmutcan Duran
Umutcan Duran
DSDila Sayman
Dila Sayman
EÖEce Özdemir Öktem
Ece Özdemir Öktem
BYBurak Yulug
Burak Yulug
ŞÇŞeyda Çankaya
Şeyda Çankaya
We present a rare case of a 38-year-old man diagnosed with third cranial nerve paralysis, where no abnormalities were detected on MRI. Human Herpes Virus-6 (HHV-6) infection affecting the central nervous system and associated with cranial nerve paralysis is an unusual occurrence. This report underscores the importance of considering HHV-6 as a differential diagnosis in patients presenting with cranial nerve palsy and suggests the use of cerebrospinal fluid (CSF) HHV-6 polymerase chain reaction (PCR) testing for confirmation.